检索结果 - Alec Wilkinson
- Showing 1 - 3 results of 3
-
1
-
2
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer 由 Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven Vensko, Mark G. Woodcock, Hsing‐Hui Wang, Sara E. Wobker, Gatphan Atassi, Alec Wilkinson, Kenneth A. Fowler, Leah M. Flick, Jeffrey S. Damrauer, Michael R. Harrison, Karen P. McKinnon, Tracy L. Rose, Matthew I. Milowsky, Jonathan S. Serody, William Y. Kim, Benjamin G. Vincent
出版 2024Artigo -
3
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia 由 Joshua F. Zeidner, Benjamin G. Vincent, Anastasia Ivanova, Dominic T. Moore, Karen P. McKinnon, Alec Wilkinson, Rupkatha Mukhopadhyay, Francesco Mazziotta, Hanna A. Knaus, Matthew C. Foster, Catherine C. Coombs, Katarzyna Jamieson, Hendrik Van Deventer, Jonathan Webster, Gabrielle T. Prince, Amy E. DeZern, B. Douglas Smith, Mark J. Levis, Nathan D. Montgomery, Leo Luznik, Jonathan S. Serody, Ivana Gojo
出版 2021Artigo
相关主题
Biology
Cancer
Chemotherapy
Immune checkpoint
Immunotherapy
Internal medicine
Medicine
Oncology
Pembrolizumab
Aminoglycoside
Antibiotics
Astrobiology
Bacteria
Biochemistry
Biofilm
Biomarker
Bladder cancer
Breast cancer
Cancer research
Chemistry
Chemotherapy regimen
Cytarabine
Genetics
Gentamicin
Immune system
Immunology
Microbiology
Mitoxantrone
Multidrug tolerance
Myeloid leukemia